AEON Biopharma, Inc. (AEON)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Income | -$12.80M | $72.98M | — | -$48.43M | -$1.94M | — |
| Net Income | -$39.22M | $42.01M | — | -$52.56M | $8.20M | — |
| EPS (Diluted) | $-3.95 | $72.93 | — | $-0.38 | — | — |
| Total Assets | $5.56M | $3.14M | $6.84M | $10.78M | $276.95M | $81.0K |
| Total Liabilities | $60.59M | $31.71M | $159.89M | $143.24M | $17.88M | $59.6K |
| Shareholders' Equity | -$55.03M | -$28.57M | -$153.04M | -$270.41M | -$223.82M | — |
| Cash & Equivalents | $3.01M | $13.0K | $5.16M | $9.75M | $497.4K | — |
| Operating Cash Flow | -$17.31M | -$20.29M | — | -$35.58M | -$1.49M | — |
| Capital Expenditures | $4.0K | — | — | $306.0K | — | — |
| Shares Outstanding | 12.11M | 555.5K | 516.4K | 138.83M | — | — |